MedicarePartD.guide

A non-government resource built from CMS public data

emtricitabine-tenofovir on HealthSpring Assurance Rx (S5617-217)

generic Truvada

Covered.

Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.

$268.06
Patient pays / month, after deductible
$686.26
Patient pays / month, before the $615.00 deductible
$804.19
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated at a preferred retail pharmacy, from the plan's negotiated price of $837.70 for a month. Other covered strengths are listed below.

All 4 covered strengths and forms
FormTierPatient pays / monthLimits
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated4$268.0630 per 30 days
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100/150 mg Tablet, Film Coated4$268.9030 per 30 days
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133/200 mg Tablet, Film Coated5$210.0830 per 30 days
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167/250 mg Tablet, Film Coated4$273.0130 per 30 days

Other HIV drugs on this plan

Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5617-217